DNMT3A and hematopoietic and lymphoid cell neoplasm: Most of DNMT3A mutations found in hematological cancers are located within the methyltransferase domain, with a higher prevalence (about 65%) of heterozygous missense mutations at codon R882 [12,36,38,39,40].